Unknown

Dataset Information

0

Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis.


ABSTRACT: BACKGROUND:The roles of soluble epoxide hydrolase and lipid mediators in inflammatory and neuropathic pain could be relevant in laminitis pain management. OBJECTIVES:To determine soluble epoxide hydrolase (sEH) activity in the digital laminae, sEH inhibitor potency in vitro, and efficacy of a sEH inhibitor as an adjunct analgesic therapy in chronic laminitic horses. STUDY DESIGN:In vitro experiments and clinical case series. METHODS:sEH activity was measured in digital laminae from euthanised healthy and laminitic horses (n = 5-6/group). Potency of 7 synthetic sEH inhibitors was determined in vitro using equine liver cytosol. One of them (t-TUCB; 0.1 mg/kg bwt i.v. every 24 h) was selected based on potency and stability, and used as adjunct therapy in 10 horses with severe chronic laminitis (Obel grades 2, one horse; 3-4, nine horses). Daily assessments of forelimb lifts, pain scores, physiologic and laboratory examinations were performed before (baseline) and during t-TUCB treatment. Data are presented as mean ± s.d. and 95% confidence intervals (CI). RESULTS:sEH activity in the digital laminae from laminitic horses (0.9±0.6 nmol/min/mg; 95% CI 0.16-1.55 nmol/min/mg) was significantly greater (P = 0.01) than in healthy horses (0.17±0.09 nmol/min/mg; CI 0.07-0.26 nmol/min/mg). t-TUCB as an adjunct analgesic up to 10 days (4.3±3 days) in laminitic horses was associated with significant reduction in forelimb lifts (36±22%; 95% CI 9-64%) and in pain scores (18±23%; 95% CI 2-35%) compared with baseline (P = 0.04). One horse developed gas colic and another corneal vascularisation in a blind eye during treatment. No other significant changes were observed. MAIN LIMITATIONS:Absence of control group and evaluator blinding in case series. CONCLUSIONS:sEH activity is significantly higher in the digital laminae of actively laminitic compared with healthy horses, and use of a potent inhibitor of equine sEH as adjunct analgesic therapy appears to decrease signs of pathologic pain in laminitic horses.

SUBMITTER: Guedes A 

PROVIDER: S-EPMC5580818 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis.

Guedes A A   Galuppo L L   Hood D D   Hwang S H SH   Morisseau C C   Hammock B D BD  

Equine veterinary journal 20160816 3


<h4>Background</h4>The roles of soluble epoxide hydrolase and lipid mediators in inflammatory and neuropathic pain could be relevant in laminitis pain management.<h4>Objectives</h4>To determine soluble epoxide hydrolase (sEH) activity in the digital laminae, sEH inhibitor potency in vitro, and efficacy of a sEH inhibitor as an adjunct analgesic therapy in chronic laminitic horses.<h4>Study design</h4>In vitro experiments and clinical case series.<h4>Methods</h4>sEH activity was measured in digit  ...[more]

Similar Datasets

| S-EPMC3597810 | biostudies-literature
| S-EPMC6335332 | biostudies-literature
| S-EPMC3703951 | biostudies-literature
| S-EPMC2788866 | biostudies-literature
| S-EPMC7991096 | biostudies-literature
| S-EPMC2533064 | biostudies-literature
| S-EPMC5828869 | biostudies-other
| S-EPMC3396292 | biostudies-literature
| S-EPMC1447601 | biostudies-literature
| S-EPMC5869703 | biostudies-literature